NEFL and Kennedy disease: NfL concentrations in blood were unchanged in 2 cohorts of patients with SBMA and in a mouse model of disease, while markers of muscle damage and mass were altered, the latter showing correlation with clinical measures of disease, suggesting that biomarkers of muscle damage and mass, rather than neuronal damage, should be used to monitor disease progression and outcome.